4438 Stock Overview
Welby Inc. provides digital health solutions that help patients to get medical care services.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Welby Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥556.00 |
52 Week High | JP¥834.00 |
52 Week Low | JP¥371.00 |
Beta | 1.27 |
1 Month Change | -1.77% |
3 Month Change | -12.58% |
1 Year Change | -12.99% |
3 Year Change | -56.43% |
5 Year Change | -86.04% |
Change since IPO | -86.84% |
Recent News & Updates
Shareholder Returns
4438 | JP Healthcare Services | JP Market | |
---|---|---|---|
7D | -10.2% | 1.7% | 1.8% |
1Y | -13.0% | -34.9% | 31.0% |
Return vs Industry: 4438 exceeded the JP Healthcare Services industry which returned -34.9% over the past year.
Return vs Market: 4438 underperformed the JP Market which returned 31% over the past year.
Price Volatility
4438 volatility | |
---|---|
4438 Average Weekly Movement | 9.2% |
Healthcare Services Industry Average Movement | 6.5% |
Market Average Movement | 4.1% |
10% most volatile stocks in JP Market | 8.1% |
10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4438's share price has been volatile over the past 3 months.
Volatility Over Time: 4438's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 53 | Takeru Hiki | www.welby.jp |
Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates apps, web services, and data management.
Welby Inc. Fundamentals Summary
4438 fundamental statistics | |
---|---|
Market cap | JP¥4.36b |
Earnings (TTM) | -JP¥505.00m |
Revenue (TTM) | JP¥575.00m |
7.6x
P/S Ratio-8.6x
P/E RatioIs 4438 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4438 income statement (TTM) | |
---|---|
Revenue | JP¥575.00m |
Cost of Revenue | JP¥199.00m |
Gross Profit | JP¥376.00m |
Other Expenses | JP¥881.00m |
Earnings | -JP¥505.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
Earnings per share (EPS) | -64.47 |
Gross Margin | 65.39% |
Net Profit Margin | -87.83% |
Debt/Equity Ratio | 0.09% |
How did 4438 perform over the long term?
See historical performance and comparison